Skip to main content Skip to footer
American Family Children's Hospital

Print Friendly Page

Protocol No. AGCT1531

Principal Investigator DeSantes, Kenneth

Phase III

Age Group Both

Scope National

Sponsor Type National

Title A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Applicable Disease Sites Bladder; Brain/Central Nervous System; Breast; Cervix; Colon and Rectum; Endocrine cancers; Esophagus; Gastrointestinal cancers, other; Genitourinary cancers, other; Head and Neck; Ill-Defined Sites; Kidney; Liver; Lung; Melanoma/Skin cancer; Ovary; Pancreas; Prostate; Sarcoma; Stomach; Thyroid; Uterus

Drugs Involved blenoxane (bleomycin); bleomycin; carboplatin; cbdca (carboplatin); cis-diamminedichloroplatinum (cisplatin); cisplatin; etoposide; paraplatin (carboplatin); platinol (cisplatin); platinum (cisplatin); vepesid (etoposide); vp-16 (etoposide)

Status Open

Participating Institutions UW Hospital and Clinics